A carregar...
Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial
Objective. Methylnaltrexone, a peripherally acting µ-opioid receptor antagonist, alleviates opioid-induced constipation. Understanding its long-term safety and efficacy profile in patients with chronic noncancer pain is warranted given the persistence of opioid-induced constipation. Methods. In this...
Na minha lista:
| Publicado no: | Pain Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5914419/ https://ncbi.nlm.nih.gov/pubmed/28810695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/pm/pnx148 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|